期刊文献+

等位基因特异PCR结合测序检测CYP21A2基因突变的方法

Establishment of an allele-specific PCR method for direct screening of CYP21A2 gene mutation
原文传递
导出
摘要 目的建立一种等位基因特异PCR结合测序检测CYP21A2基因突变的方法。方法通过对CYP21A2基因和相应假基因CYP21AP序列进行同源性比较,同时设计等位基因特异PCR引物与可扩增CYP21A2和CYP21A2P基因的同源性引物。选择4例先天性肾上腺皮质增生症患者和5名正常对照,比较等位基因特异PCR引物与同源引物测序结果。结果等位基因特异PCR引物扩增和测序分析结果显示,4例患者均存在突变,分别为IVS2—13A/C〉G、Arg356Trp和Arg149Pro,对照序列正常。同源引物扩增分析只能明确Arg149Pro突变,患者和正常对照均存在IVS2—13A/C〉G和Arg356Trp突变。结论等位基因特异PCR技术结合测序可简便可靠地进行CYP21A2基因突变检测,具有临床应用推广价值。 Objective To establish an allele-specific PCR method for detect screening of CYP21A2 gene mutation. Methods Allele-specific PCR primers and analogy primers were designed based on the sequence alignment of CYP21A2 and CYP21AP genes. Genomic DNA was extracted from blood specimens of 4 patients with 21-hydroxylase deficiency and 5 healthy controls and respectively amplified with allele- specific PCR primers and analogy primers and sequenced. Results Mutations of CYP21A2 including IVS2—13A/C〉G, Arg356Trp and Arg149Pro were found with the established method in all of the 4 patients but not in the healthy controls. When detected with the analogy primers set, IVS2- 13A/C〉G and Arg356Trp were observed in both patients and healthy controls. Conclusion The allele-specific PCR-based method is a simple, effective and reliable method for the detection of CYP21A2 gene mutation.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2014年第4期479-482,共4页 Chinese Journal of Medical Genetics
关键词 CYP21A2基因 等位基因特异PCR 同源引物 CYP21A2 gene Allele-specific PCR Analogy primer
  • 相关文献

参考文献11

  • 1Wedell A. Molecular genetics of 21-hydroxylase deficiency [J]. Endocr Dev, 2011, 20:80 -87.
  • 2Tsai LP, Lee HH. Analysis of CYP21A1P and the duplicated CYP21A2 genes[J]. Gene, 2012, 506: 261-262.
  • 3Shi MM. Technologies for individual genotyping: detection of genetic polymorphisms in drug targets and disease genes [J]. Am J Pharmacogenomics, 2002, 2: 197-205.
  • 4Li CX, Pan Q, Guo YG, et al. Construction of a multiplex allele specific PCR based universal array (ASPUA) and its application to hearing loss screening [J]. Hum Murat, 2008, 29: 306-314.
  • 5王慧,蒋玲,王萍萍,周海斌,王甲莉,宋璐璐.21-羟化酶缺乏症家系的基因突变研究[J].中华医学遗传学杂志,2007,24(6):681-684. 被引量:5
  • 6Keen-Kim D, Redman JB, Alanes RU, et al. Validation and clinical application of a locus-specific polymerase chain reaction and minisequencing-based assay for congenital adrenal hyperplasia (21 hydroxylase deficiency) [J]. J Mol Diagn, 2005, 7: 236-246.
  • 7Coeli-Lacchini FB, Turatti W, Elias PC, et al. A rational, non- radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency [J]. Gene, 2013, 526: 239-245.
  • 8Witchel SF, Azziz R. Congenital adrenal hyperplasia [J]. J Pediatr Adolese Gynecol, 2011, 24: 116-126.
  • 9赵毅,叶军,杨新文,顾学范.先天性肾上腺皮质增生症患者21-羟化酶基因启动子区域突变的初步研究[J].中华医学遗传学杂志,1999,16(3):156-159. 被引量:5
  • 10Newcomb TG, Allen KJ, Tkeshelashvili L, et al. Detection of tandem CC>TT mutations induced by oxygen radicals using mutation-specific PCR [J]. Mutat Res, 1999, 427: 21-30.

二级参考文献15

  • 1张波,陆召麟,王玥,陶红.非经典型21-羟化酶缺乏症基因型和临床特征[J].中华内分泌代谢杂志,2005,21(1):43-46. 被引量:13
  • 2J萨姆布鲁克 等 金冬雁等(译).真核基因组DNA的分析和克隆(第2版)[M].北京:科学出版社,1992.463-468.
  • 3Day DJ, Speiser PW, Schulze E, et al. Identification of non-amplifying CYP21 genes when using PCR-based diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia (CAH) affected pedigrees. Hum Mol Genet, 1996, 5:2039-2048.
  • 4Usui T, Nishisho K, Kaji M, et al. Three novel mutations in Japanese patients with 21-hydroxylase deficiency. Horm Res ,2004,61 : 126-132.
  • 5Oriola J, Plensa I, Machuca I, et al. Rapid screening method for detecting mutations in the 21-hydroxylase gene. Clin Chem, 1997,43:557-561.
  • 6Ezquieta B,Jariego C,Varela JM, et al. Microsatellite markers in the indirect anal)sis of the steroid 21-hydroxylase gene. Prenat Diagn, 1997,17 : 429-434.
  • 7Mao R, Nelson L, Kates R, et al. Prenatal diagnosis of 21-hydroxylase deficiency caused by gene conversion and rearrangements:pitfalls and molecular diagnostic solutions. Prenat Diagn, 2002,22: 1171-1176.
  • 8Robins T, Bellanne-Chantelot C, Barbaro M, et al. Characterization of novel missense mutations in CYP21 causing congenital adrenal hyperplasia. J Mol Med,2007, 85:243-251.
  • 9Kharrat M, Tardy V, M'Rad R, et al. Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation. J Clin Endocrinol Metab ,2004,89:368-374.
  • 10Tusie-Luna MT, White PC. Gene conversions and unequal crossovers between CYP21 (steroid 21-hydroxylase gene) and CYP21P involve different mechanisms. Proc Natl Acad Sci U S A, 1995,92:10796-10800.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部